ADTX Q3 2025 Earnings Deep Losses and Lack of Revenue Continue as Stock Tumbles Over 45 Atrium Therapeutics Inc RNA Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment Canopy Growth CGC Q1 2026 Earnings Deep EPS Miss Casts Shadow Over Cannabis Sector SON Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Market Signals NTRS Q1 2026 Earnings EPS Surges 143 Above Estimates Amid Solid Operating Performance Enhabit Inc EHAB Q4 2025 Earnings EPS Narrowly Misses Estimates Stock Edges Higher